click below
click below
Normal Size Small Size show me how
MSII Unit 2 Pharm
Care of Pt. w/ a blood or lymphatic disorder
Question | Answer |
---|---|
Warfarin and anisindione interfere with the manufacturing of.(Pg.467) | Vitamin K-dependent clotting factors by the liver. |
heparin cannot be taken orally because..(pg.467) | it is inactivated by gastric acid in the stomach; therefore it must be given by injection. |
the action of heparin inhibits the formation of...(pg.467) | fibrin clots, inhibits the conversion of fibrinogen to fibrin, and inactivates several of the facors necessary for clotting of the blood. |
The low-molecular-weight heparins (LMWHs)act to inhibit...(pg.467) | clotting reation by binding to antithrombin III, which inhibits the synthesis of factor X and the formation of thrombin. |
The principle adverse reaction associated with anticoagulants is..(pg.467) | Bleeding |
Oral agents for anticoagulants are Pregnancy Category..(pg.467) | X |
Antiplatelet drug therapy is designed primarily to treat pt.s at risk for..(pg.470) | acute coronary syndrome, MI, stroke, and intermittent claudication. |
Antiplatelet drugs should be discontinued...(pg.471) | 1 week before a surgical procedure... and stopped immediately if thrombocytopenic purpura (TTP) is diagnosed. |
this class of drugs dissolve blood clots that have already formed within the cell walls os a blood vessel...(pg471) | Thombolytic drugs. HINT: these drugs us ASE at the end of each drug name. |
The most COMMONLY used test to monitor heparin is the..(pg.472) | activated partial thromboplastin time (APTT) |
before administering the first dose of an anticoagulant or thrombolytic, the nurse..(pg.472) | questions the pt about all drugs taken during the previous 2-3 weeks. |
before the administration of the thrombolytic agents..(pg.472) | Blood for a complete blood count(CBC) is drawn. |
before administering each dose of warfarin, the nurse checks..(pg.473) | the prothrombin flow sheet or the laboratory report to review the current PT/INR results. |